Stockholders' Equity (Tables)

6 Months Ended

Dec. 31, 2019

Stockholders Equity Note [Line Items]

Schedule of stock option activity

	Six months ended December 31, 2019 (Unaudited)
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		89,580		$	-		-		-
Options granted		-			-		-		-
Options exercised		(5,000	)		-		-		-
Options forfeited		(4,125	)		-		-		-
Options outstanding at end of the period		80,455		$	-		7.57	$	317
Options exercisable at the end of the period		53,118		$	-		8.15	$	209
Options vested and expected to vest		80,455		$	-		7.57	$	317

Employees, directors and consultants [Member]

Stockholders Equity Note [Line Items]

Schedule of unvested restricted stock units

	Number
Unvested at the beginning of period		30,107
Granted		33,000
Vested		(46,947	)
Unvested at the end of the period		16,160

Schedule of compensation expenses

	Six months ended December 31,				Three months ended December 31,
	2019		2018		2019		2018
	(Unaudited)				(Unaudited)
Research and development expenses	$	23	$	18	$	11	$	(8	)
General and administrative expenses		59		260		49		98
	$	82	$	278	$	60	$	90

Restricted stock units [Member] | Non-employee Consultants [Member]

Stockholders Equity Note [Line Items]

Schedule of compensation expenses

	Six months ended December 31,				Three months ended December 31,
	2019		2018		2019		2018
	(Unaudited)				(Unaudited)
Research and development expenses	$	33	$	97	$	15	$	13
General and administrative expenses	$	53	$	27	$	24	$	21
	$	86	$	124	$	39	$	34

Restricted stock units [Member] | Employees, directors and consultants [Member]

Stockholders Equity Note [Line Items]

Schedule of unvested restricted stock units

	Number
Unvested at the beginning of period		795,633
Granted		18,000
Forfeited		(56,045	)
Vested		(154,208	)
Unvested at the end of the period		603,380
Expected to vest after December 31, 2019		583,360

Schedule of compensation expenses

	Six months ended December 31,				Three months ended December 31,
	2019		2018		2019		2018
	(Unaudited)				(Unaudited)
Research and development expenses	$	414	$	440	$	192	$	121
General and administrative expenses		1,049		1,354		476		623
	$	1,463	$	1,794	$	668	$	744